April 12, 2001Integrity Pharmaceutical Corp.
Recalls Isoxsuprine HCI Tablets
IN (SafetyAlerts) - The Food and
Drug Administration (FDA) said today that Integrity Pharmaceutical Corp. has recalled
certain Isoxsuprine HCI tablets because of metal particles in tablets.
This is the first public notice of
this Class II
recall issued by FDA.
(Rx) Isoxsuprine HCI tablets, 20 mg, 1,000 count.
Lot Nos. 00504, 00602, and 00603.
Integrity Pharmaceutical Corp., Fishers, Indiana.
Manufacturer, by telephone on August 14, 2000, and by letter on August 21, 2000.
Firm-initiated recall ongoing.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafetyAlerts subscribers April
12, 2001. For more information regarding the SafetyAlerts free email alert service
please click here.